Si Bone Stock Today
| SIBN Stock | USD 13.56 0.29 2.19% |
Performance0 of 100
| Odds Of DistressLess than 12
|
Si Bone is selling at 13.56 as of the 30th of November 2024; that is 2.19 percent increase since the beginning of the trading day. The stock's open price was 13.27. Si Bone has less than a 12 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Si Bone are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of June 2024 and ending today, the 30th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 17th of October 2018 | Category Healthcare | Classification Health Care |
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. The company was incorporated in 2008 and is headquartered in Santa Clara, California. The company has 41.94 M outstanding shares of which 1.27 M shares are at this time shorted by private and institutional investors with about 2.75 trading days to cover. More on Si Bone
Moving against SIBN Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
SIBN Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| President | Carlton Reckling | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsSi Bone can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Si Bone's financial leverage. It provides some insight into what part of Si Bone's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Si Bone (SIBN) is traded on NASDAQ Exchange in USA. It is located in 471 El Camino Real, Santa Clara, CA, United States, 95050 and employs 344 people. Si Bone is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 568.68 M. Si Bone conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 41.94 M outstanding shares of which 1.27 M shares are at this time shorted by private and institutional investors with about 2.75 trading days to cover.
Si Bone currently holds about 114.41 M in cash with (18.71 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.34.
Check Si Bone Probability Of Bankruptcy
Ownership AllocationSi Bone secures a total of 41.94 Million outstanding shares. The majority of Si Bone outstanding shares are owned by institutions. These other corporate entities are usually referred to as non-private investors looking to take positions in Si Bone to benefit from reduced commissions. Thus, outside corporations are subject to a different set of regulations than regular investors in Si Bone. Please pay attention to any change in the institutional holdings of Si Bone as this could imply that something significant has changed or is about to change at the company. Also note that nearly four hundred twenty-seven thousand seven hundred seventy invesors are currently shorting Si Bone expressing very little confidence in its future performance.
Check SIBN Ownership Details
SIBN Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| State Street Corp | 2024-06-30 | 1 M | |
| Wellington Management Company Llp | 2024-06-30 | 993 K | |
| Morgan Stanley - Brokerage Accounts | 2024-06-30 | 989.4 K | |
| Geode Capital Management, Llc | 2024-09-30 | 924 K | |
| Nuveen Asset Management, Llc | 2024-06-30 | 871.3 K | |
| Next Century Growth Investors Llc | 2024-06-30 | 845.4 K | |
| Kent Lake Capital Llc | 2024-06-30 | 800 K | |
| Holocene Advisors, Lp | 2024-09-30 | 585.3 K | |
| Impax Asset Management Group Plc | 2024-06-30 | 536.9 K | |
| Brown Advisory Holdings Inc | 2024-09-30 | 4 M | |
| Blackrock Inc | 2024-06-30 | 3.8 M |
Si Bone Historical Income Statement
SIBN Stock Against Markets
Si Bone Corporate Management
| Anshul Maheshwari | Chief Officer | Profile | |
| Aimee Einstein | Vice Culture | Profile | |
| Daniel Cher | Senior Affairs | Profile | |
| Michael Pisetsky | General Counsel and Chief Compliance Officer | Profile | |
| Laura MBA | CEO Director | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Si Bone. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. To learn how to invest in SIBN Stock, please use our How to Invest in Si Bone guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Si Bone. If investors know SIBN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Si Bone listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.91) | Revenue Per Share 3.817 | Quarterly Revenue Growth 0.186 | Return On Assets (0.12) | Return On Equity (0.22) |
The market value of Si Bone is measured differently than its book value, which is the value of SIBN that is recorded on the company's balance sheet. Investors also form their own opinion of Si Bone's value that differs from its market value or its book value, called intrinsic value, which is Si Bone's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Si Bone's market value can be influenced by many factors that don't directly affect Si Bone's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Si Bone's value and its price as these two are different measures arrived at by different means. Investors typically determine if Si Bone is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Si Bone's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.